2020
DOI: 10.1002/hep.30953
|View full text |Cite
|
Sign up to set email alerts
|

Hepatocyte ELOVL Fatty Acid Elongase 6 Determines Ceramide Acyl‐Chain Length and Hepatic Insulin Sensitivity in Mice

Abstract: BaCKgRoUND aND aIMS:Dysfunctional hepatic lipid metabolism is a cause of nonalcoholic fatty liver disease (NAFLD), the most common chronic liver disorder worldwide, and is closely associated with insulin resistance and type 2 diabetes. ELOVL fatty acid elongase 6 (Elovl6) is responsible for converting C16 saturated and monounsaturated fatty acids (FAs) into C18 species. We have previously shown that Elovl6 contributes to obesity-induced insulin resistance by modifying hepatic C16/C18-related FA composition. ap… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
31
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 53 publications
(36 citation statements)
references
References 52 publications
4
31
0
1
Order By: Relevance
“…Thus, effects may be tissue specific. Recently, it has been shown that the lipid enzyme CerS4, that generates C18‐ and C20‐ceramides, contribute to hepatic insulin resistance 31 . Consistently, in HFD‐fed mice, we observed increases in hepatic C18‐, C20‐, and C22‐ceramides and the NA‐supplemented diet returned C20‐ and C22‐ceramides back to control levels.…”
Section: Discussionsupporting
confidence: 87%
“…Thus, effects may be tissue specific. Recently, it has been shown that the lipid enzyme CerS4, that generates C18‐ and C20‐ceramides, contribute to hepatic insulin resistance 31 . Consistently, in HFD‐fed mice, we observed increases in hepatic C18‐, C20‐, and C22‐ceramides and the NA‐supplemented diet returned C20‐ and C22‐ceramides back to control levels.…”
Section: Discussionsupporting
confidence: 87%
“…Previous studies in mammals have verified the crucial role of elovl6 in insulin resistance [3,19]. Mice with a global deficiency for elovl6 could protect against diet-induced insulin resistance [3], and elovl6 specific deletion in the liver of mice ameliorated insulin resistance by reducing hepatic ceramide and protein phosphatase 2A activity [20]. However, studies on the relationship between elovl6 and insulin in fish have not been reported to date.…”
Section: Discussionmentioning
confidence: 99%
“…Néanmoins, plusieurs études récentes montrent une implication des céramides hépatiques dans l'apparition de la stéatose et de la résistance hépatique à l'insuline [33][34][35][36][37][38]. Selon le tissu étudié, des espèces différentes de céramides peuvent être impliquées.…”
Section: Mécanisme D'action Des Céramidesunclassified